Amgen Inc 2020 SR
The report highlights Amgen's progress in 2020, focusing on its response to COVID-19, commitment to carbon neutrality by 2027, and efforts in diversity and inclusion. Key achievements include providing $1.5 billion in medicines to low-income patients through the Amgen Safety Net Foundation and becoming a founding member of the OneTen coalition. The company also surpassed its 2020 environmental targets ahead of schedule, reducing carbon emissions by 33% since 2007. Additionally, Amgen launched the RISE initiative to increase diversity in clinical trials.
Company: Amgen Inc
Sector: Manufacturing
Country: United States
Year: 2020
Type: SR
Pages: 76
Back to company
Amgen Inc
ESG Report
The report highlights Amgen's progress in 2020, focusing on its response to COVID-19, commitment to carbon neutrality by 2027, and efforts in diversity and inclusion. Key achievements include providing $1.5 billion in medicines to low-income patients through the Amgen Safety Net Foundation and becoming a founding member of the OneTen coalition. The company also surpassed its 2020 environmental targets ahead of schedule, reducing carbon emissions by 33% since 2007. Additionally, Amgen launched the RISE initiative to increase diversity in clinical trials.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2020
Reporting Period
Jan 1, 2020 - Dec 31, 2020
Fiscal Year
2020
Published
May 18, 2021
Type
Sustainability Report
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
Assurance
Assurance Provider
Sustainable Development Goals
Other Standards
ESG Data?Experimental: AI-extracted data, may contain inaccuracies
Emissions
Scope 1:
Scope 2:
Energy Consumption
Renewable Energy
Water Consumption
Total Waste
Women in Management
Net Zero Target
Employees